Quackenbush-Baker v. Secretary of Health and Human Services

United States Court of Federal Claims·Decided August 27, 2018·No. 14-1000·Unpublished

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS Filed: July 31, 2018

* * * * * * * * * * * * * * * * * * * ERIN QUACKENBUSH-BAKER, * UNPUBLISHED * Petitioner, * No. 14-1000V v. * * Special Master Gowen SECRETARY OF HEALTH * AND HUMAN SERVICES, * Attorneys’ Fees and Costs; * Special Master’s Discretion. Respondent. * * * * * * * * * * * * * * * * * * * *

Curtis R. Webb, Twin Falls, ID, for petitioner. Christine M. Becer, United States Department of Justice, Washington, DC, for respondent.

DECISION ON FINAL ATTORNEYS’ FEES AND COSTS1

On October 16, 2014, Erin Quackenbush-Baker (“petitioner”) filed a claim for compensation pursuant to the National Vaccine Injury Compensation Program.2 Petitioner alleged that as a result of receiving a trivalent influenza (“flu”) vaccination on November 20, 2013, she has experienced a significant aggravation of a pre-existing but asymptomatic multiple sclerosis (“MS”). Petition (ECF No. 1).

On March 14, 2018, the undersigned ruled that petitioner had established entitlement to compensation based on a theory of causation in fact. Ruling on Entitlement (ECF No. 89). Afterwards, respondent filed a Proffer on an award of compensation, which indicated petitioner’s agreement on the terms set forth therein. Proffer (ECF No. 95). I issued a decision approving compensation consistent with the proffer. Decision on Damages (ECF No 98). After the parties

1 Pursuant to the E-Government Act of 2002, see 44 U.S.C. § 3501 note (2012), because this unpublished ruling contains a reasoned explanation for the action in this case, I intend to post it on the website of the United States Court of Federal Claims. The court’s website is at http://www.uscfc.uscourts.gov/aggregator/sources/7. Before the ruling is posted on the court’s website, each party has 14 days to file a motion requesting redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). “An objecting party must provide the court with a proposed redacted version” of the ruling. Id. If neither party files a motion for redaction within 14 days, the ruling will be posted on the court’s website without any changes. Id. 2 The National Vaccine Injury Compensation Program is set forth in Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755, codified as amended, 42 U.S.C. §§ 300aa-1 to 34 (2012) (“Vaccine Act” or “the Act”). All citations in this decision to individual sections of the Vaccine Act are to 42 U.S.C.A. § 300aa. filed a joint notice not to seek review (ECF No. 102), the Clerk of the Court entered judgment on the Proffer on July 6, 2018 (ECF No. 103).

I previously granted petitioner’s first motion for interim attorneys’ fees and costs incurred through March 9, 2016, in the total amount of $94,972.42. Petitioner’s Motion (“Pet. Mot.”) for First Interim Award (ECF No. 37); Decision (ECF No. 49).

On June 21, 2018, petitioner filed a motion for a final award of attorneys’ fees and costs incurred from March 9, 2016 through the present. She has requested $215,731.04 in attorneys’ fees and $53,890.06 in attorneys’ costs, for a total request of $269,621.10. Pet. Mot. for Final Award, filed June 21, 2018 (ECF No. 99).3 In accordance with General Order #9, petitioner has submitted her signed statement that she has incurred no costs in the prosecution of this claim and no retainer was paid to counsel. Petitioner’s Statement (ECF No. 100).

On July 5, 2018, respondent filed a response to petitioners’ motion. Respondent’s (“Resp.”) Response (ECF No. 101). Respondent argued that “[n]either the Vaccine Act nor Vaccine Rule 13 contemplates any role for respondent in the resolution of a request by a petitioner for an award of attorneys’ fees and costs.” Id. at 1. Further, respondent “is satisfied the statutory requirements for an award of attorneys’ fees and costs are met in this case.” Id. at 2. Respondent “respectfully recommends that the Special Master exercise his discretion and determine a reasonable award for attorneys’ fees and costs.” Id. at 3. Petitioner did not file a reply. This matter is now ripe for adjudication.

I. Discussion

Under the Vaccine Act, the special master shall award reasonable attorneys’ fees and costs for any petition that results in an award of compensation. §15(e). Based on my ruling on entitlement and the parties’ proffer, petitioner has been awarded compensation. She is therefore entitled to a final award of reasonable attorneys’ fees and costs.

A. Reasonable Attorneys’ Fees

The Federal Circuit has approved use of the lodestar approach to determine reasonable attorneys’ fees and costs under the Vaccine Act. Avera v. Sec’y of Health & Human Servs., 515 F.3d 1343, 1349 (Fed. Cir. 2008). Using the lodestar approach, a court first determines “an initial estimate of a reasonable attorneys’ fee by ‘multiplying the number of hours reasonably expended on the litigation times a reasonable hourly rate.’” Id. at 1347-58 (quoting Blum v. Stenson, 465 U.S. 886, 888 (1984)). Then, the court may make an upward or downward departure from the initial calculation of the fee award based on other specific findings. Id. at 1348. Special masters have “wide discretion in determining the reasonableness” of attorneys’

3 As referenced herein, on January 24, 2018, petitioner filed a motion for a second interim attorneys’ fees and costs award. Pet. Mot. for Second Interim Award (ECF No. 49). This motion details the requested fees and costs incurred between March 25, 2016 – November 28, 2017. Respondent did not file a response to this motion. Shortly thereafter, in March 2018, I issued my ruling on entitlement (ECF No. 89), followed by an order denying petitioner’s motion for a second interim award and directing the parties to resolve damages promptly (ECF No. 90).

2 fees and costs, Perreira v. Sec’y of Health & Human Servs., 27 Fed. Cl. 29, 34 (1992), aff’d, 33 F.3d 1375 (Fed. Cir. 1994), and may increase or reduce the initial fee award calculation based on specific findings. Avera, 515 F.3d at 1348.

In making reductions, a line-by-line evaluation of the fee application is not required. Wasson, 24 Cl. Ct. at 484, rev’d on other grounds and aff’d in relevant part, 988 F.2d 131 (Fed. Cir. 1993). Special masters may rely on their experience with the Vaccine Act and its attorneys to determine the reasonable number of hours expended. Id. Just as “[t]rial courts routinely use their prior experience to reduce hourly rates and the number of hours claimed in attorney fee requests . . . [v]accine program special masters are also entitled to use their prior experience in reviewing fee applications.” Saxton v. Sec’y of Health & Human Servs., 3 F.3d 1517, 1521 (Fed. Cir. 1993).

i. Reasonable Hourly Rate

Under the lodestar approach, the first step is to determine reasonable hourly rates for the individuals at issue.

Free access — add to your briefcase to read the full text and ask questions with AI

Quackenbush-Baker v. Secretary of Health and Human Services, (uscfc 2018).

Quackenbush-Baker v. Secretary of Health and Human Services (Quackenbush-Baker v. Secretary of Health and Human Services) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related